AlphaMaven AlphaMaven

Private credit is not ‘a cancer’, says Wall Street’s top prosecutor

Reported by FT
May 13, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • Manhattan U.S. Attorney Jay Clayton, Wall Street's top federal prosecutor, publicly defended the private credit industry, stating it is "a great benefit to the U.S." and explicitly rejecting characterizations of it as problematic or predatory.
  • • Clayton's endorsement represents a significant regulatory signal that the private credit sector—which has experienced substantial growth as institutional investors seek alternatives to traditional banking—does not face imminent enforcement action or systematic investigation from federal authorities.
  • • The statement carries particular weight given Clayton's previous role as SEC Chair and his current position overseeing federal prosecutions in the Southern District of New York, making him one of the most influential voices in financial regulation and enforcement.
Summary
Manhattan U.S. Attorney Jay Clayton has delivered a forceful defense of the private credit industry, dismissing concerns that have surfaced about its rapid expansion and competitive threat to traditional banking. In remarks reported by the Financial Times, Clayton characterized private credit as "a great benefit to the U.S.," directly countering narratives that have depicted the sector as problematic or exploitative. His framing explicitly rejects the notion that private credit operates as a "cancer" within financial markets.

Clayton's statement carries substantial regulatory weight. As the head of the U.S. Attorney's Office for the Southern District of New York—one of the nation's most consequential prosecution jurisdictions for financial crimes and securities enforcement—his public position signals that the federal government does not view the private credit industry as facing systematic legal jeopardy. The endorsement is further amplified by Clayton's previous tenure as SEC Chair, which established his credibility and influence across regulatory circles.

The timing of Clayton's remarks reflects ongoing debate about private credit's role in the financial ecosystem. The sector has grown significantly in recent years as institutional investors, including pension funds, insurance companies, and family offices, have deployed capital into direct lending and structured credit vehicles as alternatives to traditional bank financing. This growth has prompted both industry champions and skeptics to make competing claims about systemic risk, borrower protections, and competitive dynamics with regulated banks.

Clayton's characterization as a "great benefit" suggests the federal government views private credit as supporting legitimate economic functions—particularly in providing capital to middle-market companies and financing activities that traditional banks may no longer serve adequately. The statement implies that regulatory authorities do not currently perceive the sector as requiring enhanced enforcement scrutiny or structural restrictions.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

FT Private credit is not ‘a cancer’, says Wall Street’s top prosecutor